Ellume, Author at Ellume

Ellume awarded US$30M from US National Institutes of Health RADx initiative to accelerate development of rapid COVID-19 diagnostics

Brisbane, Australia — 7 October 2020 Ellume, a leader in rapid digital diagnostics, today announced it was successfully awarded US$30million from the U.S. National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) initiative to accelerate the clinical testing and manufacturing scale-up of the company’s COVID-19 antigen tests. Ellume’s core fluorescent immunoassay platform has been […]

Brisbane biotech company to send millions of COVID-19 tests to US

Digital diagnostics company Ellume has already shipped the first batch from the initial order of 900,000 test kits to the US, and will bring online in October a larger facility at Richlands that has a capacity of 15 million units a month.

Experts push for faster coronavirus tests to help Australia adapt to a new ‘COVID-normal’

Queensland-based digital diagnostics company Ellume has developed an antibody test that gives a result in less than 15 minutes and has already sold 900,000 tests to the United States.

Ellume appoints Joanne Moss to its Board as Non-executive Director

Brisbane, Australia – 12 November 2019 Ellume Limited (Ellume) is pleased to announce the appointment of Ms Joanne Moss to its Board as an Independent Non-Executive Director and Chair of Audit and Risk, effective immediately. This appointment supports Ellume’s commitment to good governance and strengthens management resources in preparation for US commercialisation and potential upcoming […]

How Digital Diagnostics Are Changing Healthcare

The Importance of Accurate Tests to Good Medicine – Despite advances in healthcare over recent decades, infectious diseases remain burdensome illnesses. Influenza kills more people in America than car accidents, tuberculosis kills over 5,000 people every day around the world, and antimicrobial resistance is a growing threat.

The 10 most innovative health companies

The AFR BOSS Most Innovative Companies list recognises the most innovative organisations in Australia and New Zealand, as judged by the expert panel assembled by The Australian Financial Review and Inventium.

From the emergency ward to pitching an IPO

Sean Parsons was a medical emergency doctor during the 2009 swine flu pandemic in Queensland when he decided to develop a home-test kit for the flu.

Flu-diagnostics startup Ellume raises $5 million as it gears up for IPO

Brisbane Medtech startup Ellume has secured $5 million in funding for commercialising and developing its diagnostics products as it ramps up to listing on the ASX.

Ellume, the digital diagnostics company helping people beat the flu

Dr Sean Parsons is the founder of Ellume, an emerging digital diagnostics company situated in Brisbane that provides smart, self-use diagnostics for the detection and management of pandemic influenza.

Meet the Aussie entrepreneur letting you diagnose the flu through your smartphone

Imagine being able to accurately diagnose common illnesses such as the flu, submit that diagnosis to a medical professional, and receive advice and a prescription for treatment, all without ever having to leave your bed.

Page 2 of 3123